Hidekazu Tachibana, MD, PHD

Saiseikai Kazo Hospital

Disclosure information not submitted.

Presentation(s):

• MP12-04: Predictive impact of early changes in serum C-reactive protein levels in nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma

  Friday, May 13, 2022
  1:00 PM – 2:15 PM